FDA requires warnings on anti-malaria drug Lariam.
D000962:Antimalarials / Q000009:adverse effects*; D003257:Consumer Product Safety; D004348:Drug Labeling; D006801:Humans; D015767:Mefloquine / Q000009:adverse effects*; D001523:Mental Disorders / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
D000962:Antimalarials; D015767:Mefloquine